Kalani M Yashar S, Elhadi Ali M, Ramey Wyatt, Nakaji Peter, Albuquerque Felipe C, McDougall Cameron G, Zabramski Joseph M, Spetzler Robert F
Division of Neurological Surgery, Barrow Neurological Institute, Saint Joseph's Hospital and Medical Center, Phoenix, Arizona.
J Neurosurg Pediatr. 2014 Jun;13(6):641-6. doi: 10.3171/2014.3.PEDS13444. Epub 2014 Apr 18.
Aneurysms are relatively rare in the pediatric population and tend to include a greater proportion of large and giant lesions. A subset of these large and giant aneurysms are not amenable to direct surgical clipping and require complex treatment strategies and revascularization techniques. There are limited data available on the management of these lesions in the pediatric population. This study was undertaken to evaluate the outcome of treatment of large and giant aneurysms that required microsurgical revascularization and vessel sacrifice in this population.
The authors retrospectively identified all cases in which pediatric patients (age < 18 years) with aneurysms were treated using cerebral revascularization in combination with other treatment modalities at their institution between 1989 and 2013.
The authors identified 27 consecutive patients (19 male and 8 female) with 29 aneurysms. The mean age of the patients at the time of treatment was 11.5 years (median 13 years, range 1-17 years). Five patients presented with subarachnoid hemorrhage, 11 with symptoms related to mass effect, 2 with stroke, and 3 with seizures; in 6 cases, the aneurysms were incidental findings. Aneurysms were located along the internal carotid artery (n = 7), posterior cerebral artery (PCA) (n = 2), anterior cerebral artery (n = 2), middle cerebral artery (MCA) (n = 14), basilar artery (n = 2), vertebral artery (n = 1), and at the vertebrobasilar junction (n = 1). Thirteen were giant aneurysms (45%). The majority of the aneurysms were fusiform (n = 19, 66%), followed by saccular (n = 10, 34%). Three cases were previously treated using microsurgery (n = 2) or an endovascular procedure (n = 1). A total of 28 revascularization procedures were performed, including superficial temporal artery (STA) to MCA (n = 6), STA to PCA (n = 1), occipital artery to PCA (n = 1), extracranial-intracranial (EC-IC) bypass using radial artery graft (n = 3), EC-IC using a saphenous vein graft (n = 7), STA onlay (n = 3), end-to-end anastomosis (n = 1), and in situ bypasses (n = 6). Perioperative stroke occurred in 4 patients, but only one remained dependent (Glasgow Outcome Scale [GOS] score 3). At a mean clinical follow-up of 46 months (median 14 months, range 1-232 months), 26 patients had a good outcome (GOS score 4 or 5). There were no deaths. Five patients had documented occlusion of the bypass graft. The majority of aneurysms (n = 24) were obliterated at last follow-up. There was a single case of a residual aneurysm and one case of recurrence. Angiographic follow-up was unavailable in 3 cases.
Cerebral revascularization remains an essential tool in the treatment of complex cerebral aneurysms in children.
动脉瘤在儿科人群中相对罕见,且往往包含较大比例的大型和巨型病变。这些大型和巨型动脉瘤中的一部分不适合直接手术夹闭,需要复杂的治疗策略和血管重建技术。关于儿科人群中这些病变的治疗,可用数据有限。本研究旨在评估在该人群中需要显微外科血管重建和血管牺牲的大型和巨型动脉瘤的治疗结果。
作者回顾性确定了1989年至2013年间在其机构接受脑血运重建联合其他治疗方式治疗的所有儿科动脉瘤患者(年龄<18岁)病例。
作者确定了27例连续患者(19例男性和8例女性),共29个动脉瘤。治疗时患者的平均年龄为11.5岁(中位数13岁,范围1 - 17岁)。5例患者表现为蛛网膜下腔出血,11例有与占位效应相关的症状,2例有中风,3例有癫痫发作;6例中,动脉瘤为偶然发现。动脉瘤位于颈内动脉(n = 7)、大脑后动脉(PCA)(n = 2)、大脑前动脉(n = 2)、大脑中动脉(MCA)(n = 14)、基底动脉(n = 2)、椎动脉(n = 1)以及椎基底动脉交界处(n = 1)。13个为巨型动脉瘤(45%)。大多数动脉瘤为梭形(n = 19,66%),其次为囊状(n = 10,34%)。3例患者先前接受过显微手术(n = 2)或血管内手术(n = 1)。共进行了28次血管重建手术,包括颞浅动脉(STA)至MCA(n = 6)、STA至PCA(n = 1)、枕动脉至PCA(n = 1)、使用桡动脉移植物的颅外 - 颅内(EC - IC)旁路(n = 3)、使用大隐静脉移植物的EC - IC旁路(n = 7)、STA覆盖(n = 3)、端端吻合(n = 1)以及原位旁路(n = 6)。4例患者发生围手术期中风,但仅1例仍有功能障碍(格拉斯哥预后量表[GOS]评分为3分)。平均临床随访46个月(中位数14个月,范围1 - 232个月)时,26例患者预后良好(GOS评分为4或5分)。无死亡病例。5例患者记录有旁路移植物闭塞。大多数动脉瘤(n = 24)在最后一次随访时闭塞。有1例残留动脉瘤和1例复发。3例未进行血管造影随访。
脑血运重建仍然是治疗儿童复杂脑动脉瘤的重要手段。